Current Pharmaceutical Design
Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
   |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Pharmaceutical Design, Volume 13 - Number 10
Editorial [Hot Topic:Stabilizing the Vulnerable Plaque: The Search for the Magic Bullet (Executive Editors: G. Pasterkamp and M. Daemen)]
, 13(10): 979 - 982Gerard Pasterkamp and Mat Daemen
DOI: 10.2174/138161207780487539
Activation of the Innate Immune System in Atherosclerotic Disease
, 13(10): 983 - 994M. M. Oude Nijhuis, J. K. van Keulen, G. Pasterkamp, P. H. Quax and D. P. V. de Kleijn
DOI: 10.2174/138161207780487593
Current Diagnostic Modalities for Vulnerable Plaque Detection
, 13(10): 995 - 1001Johannes A. Schaar, Frits Mastik, Evelyn Regar, Cornelis A. den Uil, Frank J. Gijsen, Jolanda J. Wentzel, Patrick W. Serruys and A. F. W. van der Stehen
DOI: 10.2174/138161207780487511
Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?
, 13(10): 1003 - 1012Fatima Akdim, Sander I. van Leuven, John J. P. Kastelein and Erik S. G. Stroes
DOI: 10.2174/138161207780487548
Animal Models to Study Plaque Vulnerability
, 13(10): 1013 - 1020K. Schapira, S. Heeneman and M. J. A.P. Daemen
DOI: 10.2174/138161207780487575
Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
, 13(10): 1021 - 1030Jan Nilsson, Gunilla Nordin Fredrikson, Alexandru Schiopu, Prediman K. Shah, Bo Jansson and Roland Carlsson
DOI: 10.2174/138161207780487557
Chemokines and Atherosclerotic Plaque Progression: Towards Therapeutic Targeting?
, 13(10): 1039 - 1052A. O. Kraaijeveld, S. C. A. de Jager, T. J. C. van Berkel, E. A. L. Biessen and J. W. Jukema
DOI: 10.2174/138161207780487584
Restoring the Dysfunctional Endothelium
, 13(10): 1053 - 1068Elena Osto, Giuseppe Coppolino, Massimo Volpe and Francesco Cosentino
DOI: 10.2174/138161207780487566
Multi-Constituent Cardiovascular Pills (MCCP) - Challenges and Promises of Population-Based Prophylactic Drug Therapy for Prevention of Heart Attack
, 13(10): 1069 - 1076Michael J. Jamieson and Morteza Naghavi
DOI: 10.2174/138161207780487601
Editor-in-Chief
William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)
Biography
View Full Editorial Board
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
Biography
Biography of William A. Banks
Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32
Advertisement
Webmaster Contact: info@benthamscience.net